Boston Scientific (BSX) Divestments (2009 - 2022)

Boston Scientific has disclosed Divestments across 9 years of filings, most recently posting $5.0 million for Q1 2022.

• In Q1 2022, Divestments fell 99.38% year-over-year to $5.0 million; the TTM figure through Dec 2022 stood at $5.0 million (down 99.39% YoY), while the FY2022 annual figure was $5.0 million, down 99.39% from the prior year.
• Divestments came in at $5.0 million for Q1 2022 at Boston Scientific, down from $25.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $801.0 million in Q1 2021 to a low of $5.0 million in Q1 2022.
• Average Divestments over 4 years is $187.2 million, with a median of $25.0 million recorded in 2021.
• The largest YoY upside for Divestments was 99.38% in 2022 against a maximum downside of 99.38% in 2022.
• Over 4 years, Divestments stood at $90.0 million in 2019, then slumped by 83.33% to $15.0 million in 2020, then jumped by 66.67% to $25.0 million in 2021, then sank by 80.0% to $5.0 million in 2022.
• Per Business Quant data, the three most recent Divestments figures were $5.0 million in Q1 2022, $25.0 million in Q4 2021, and $801.0 million in Q1 2021.